PnPP-19 Peptide as a Novel Drug Candidate for Topical Glaucoma Therapy Through Nitric Oxide Release

PURPOSE: Evaluation of PnPP-19 safety and efficacy in reducing the intraocular pressure (IOP) of animals with healthy (normotensive) and ocular hypertensive eyes. PnPP-19 is a synthetic peptide designed from Phoneutria nigriventer spider toxin PnTx2-6. METHODS: Toxicity tests used chicken chorioalla...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Carolina Nunes, Dourado, Lays Fernanda Nunes, de Lima, Maria Elena, da Silva Cunha-Jr, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422904/
https://www.ncbi.nlm.nih.gov/pubmed/32855879
http://dx.doi.org/10.1167/tvst.9.8.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422904/
https://www.ncbi.nlm.nih.gov/pubmed/32855879
http://dx.doi.org/10.1167/tvst.9.8.33

Ejemplares similares